Pharmacy Closures, Generic Spend, GLP-1 Use, and More Hot Topics in Managed Care
A keynote session at the AMCP 2025 Annual Meeting addressed timely pharmaceutical market trends and predicted how the healthcare industry will be impacted over...
Improvement in Migraine Treatment, Management Has Impact on Quality of Life
Migraines are a neurobiological disorder that impact patients’ quality of life. New therapies are offering promising improvements in migraine prevention and treatment, and managed...
Clinical Trials Show Impact of GLP-1 Agonists for Conditions Other Than Diabetes, Obesity
Glucagon-like peptide (GLP)–1 inhibitors are being studied for the treatment of obesity-related comorbidities such as obstructive sleep apnea (OSA), substance use disorder (SUD), heart...
A Look at Key Specialty Pharmaceuticals in the Pipeline
A session at the AMCP 2025 Annual Meeting outlined the rapidly expanding specialty pharmacy industry, offering important information on therapeutics in development and how...
How Can AI Be Incorporated Into the Reimbursement Process?
Artificial intelligence (AI) can play a role in systematic literature reviews but should not replace human involvement, according to an analysis presented at the...